Leading the Fight

From coast-to-coast-to-coast, advocates, volunteers and partners are helping to advance our fight against diabetes

Please upgrade your Flash Player to view this video.

Eli Lilly Canada Inc. - Toronto, ON

Since Lilly’s introduction of the world’s first commercially-available insulin in 1923, we have been dedicated to the discovery of innovative therapies to address the critical needs of people living with and treating diabetes.

Each person living with diabetes faces unique challenges that can make success difficult to achieve. And success in diabetes is about more than achieving glycemic control; it’s about slowing the progression of the disease and living a longer, healthier and fuller life.

To help overcome the challenges of diabetes - for individuals, healthcare professionals and communities - Lilly is committed to providing practical day-to-day support and resources for people living with and treating this disease.

The discovery of insulin took place 90 years ago. Lilly has been engaged in diabetes research and treatment since the beginning. Through ongoing knowledge exchange, numerous research and medical education programs, grants and training for scientists and healthcare professionals, Lilly continues to provide innovative approaches for treating diabetes - personal solutions for everyday life.

Michael Mason, President and General Manager, Eli Lilly Canada Inc.
Loren Grossman, Vice-President, Research and Development, Eli Lilly Canada Inc.
Mark Pemberton, Vice-President, Diabetes, Eli Lilly Canada Inc.